Influenza A virus A/Singapore/GP1908/2015 IVR-180A (H1N1) antigen (propiolactone inactivated) Completed Phase 3 Trials for Humans / Flu caused by Influenza / Viral Disease Prevention

Indications	Status	Purpose	Phase
DBCOND0045749 (Humans) DBCOND0021701 (Flu caused by Influenza) DBCOND0045704 (Viral Disease)	Completed	Prevention	3

clinicaltrials.gov Identifier	Title	Drugs
NCT04074928	Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects	Influenza A virus A/Brisbane/10/2010 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) (DB10998) Influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen (MDCK cell derived, propiolactone inactivated) (DB14465) Influenza A virus A/Singapore/GP1908/2015 IVR-180A (H1N1) antigen (propiolactone inactivated) (DB14468) Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (propiolactone inactivated) (DB14592) Influenza B virus B/Hong Kong/259/2010 antigen (MDCK cell derived, propiolactone inactivated) (DB14464) Influenza B virus B/Maryland/15/2016 antigen (propiolactone inactivated) (DB14593) Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (propiolactone inactivated) (DB14470) Influenza B virus B/Utah/9/2014 antigen (MDCK cell derived, propiolactone inactivated) (DB11002)